This document discusses hereditary cancer screening tests. It explains that genetic testing can detect inherited mutations in cancer genes that increase cancer risk. Finding such mutations allows for increased cancer screening and prevention. The document provides details on cancer development, hereditary vs sporadic cancer, common questions about genetic testing and cancer risk, and who might benefit from hereditary cancer screening tests. It aims to inform readers about the use of these tests to detect inherited cancer susceptibility.
This document discusses hereditary cancer screening tests. It explains that genetic testing can detect inherited mutations in cancer genes that increase cancer risk. Finding such mutations allows for increased cancer screening and prevention. The document provides details on cancer development, hereditary vs sporadic cancer, common questions about genetic testing and cancer risk, and who might benefit from hereditary cancer screening tests. It aims to inform readers about the use of these tests to detect inherited cancer susceptibility.
This document discusses hereditary cancer screening tests. It explains that genetic testing can detect inherited mutations in cancer genes that increase cancer risk. Finding such mutations allows for increased cancer screening and prevention. The document provides details on cancer development, hereditary vs sporadic cancer, common questions about genetic testing and cancer risk, and who might benefit from hereditary cancer screening tests. It aims to inform readers about the use of these tests to detect inherited cancer susceptibility.
This document discusses hereditary cancer screening tests. It explains that genetic testing can detect inherited mutations in cancer genes that increase cancer risk. Finding such mutations allows for increased cancer screening and prevention. The document provides details on cancer development, hereditary vs sporadic cancer, common questions about genetic testing and cancer risk, and who might benefit from hereditary cancer screening tests. It aims to inform readers about the use of these tests to detect inherited cancer susceptibility.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 14
OBJECTIVE
INTRODUCTION WHATS CANCER WHEN IT SHOULD BE ASKED TO DETECT HOW DOES IT WORK WHAT DOES THE TEST IS USED FOR INTRODUCTION
PreSENTIA hereditary cancer test panels can detect numerous inherited
genetic changes (mutations) that could cause cancer in the future. PreSENTIA offers an extensive portfolio of 19 hereditary cancer test panels. Each panel focuses on a set of genes that determine someone’s chances of developing a specific cancer in the future. The genetic changes in the genes that could cause cancer are inherited from parents to their children, and are present from birth. Knowing that a person carries one of these genetic mutations can help them take preventative measures and plan a more informed clinical management. As a result, early detection of cancer can be achieved – which increases the chances of successful treatment – or prevention. WHAT IS CANCER?
Cancer is the rapid and uncontrollable growth of
abnormal cells. It is the second leading cause of death, responsible for 1 out of 6 deaths globally. World Health Organization (WHO) recommends that cancer mortality can be significantly reduced by early detection and proper clinical management of cancers. • What are mutations?A mutation is a change that happens in the DNA that could possibly affect the health of an individual. • What is genetic testing?Genetic testing identifies changes in the DNA. • What is cancer susceptibility and cancer predisposition?Cancer susceptibility, or predisposition, is the likelihood of being affected by cancer in the future. This depends on an individual’s DNA. There are certain inherited, genetic changes that raise someone’s risk of developing cancer in the future. This is because these changes happen in genes that are responsible for protecting the body from disease, and when they are affected, their protective role halts. • What are germline mutations?Germline mutations are changes in the DNA that are inherited from parents to their children. These changes are present from birth in all the cells in the body. Germline mutations are different from somatic mutations, which occur when a genetic change happens in the DNA due to exposure to risk factors – after a person is born. People with germline mutations in a cancer gene have a higher chance of developing cancer in their lifetime. If cancer develops due to a germline mutation, it is called hereditary cancer. • What is hereditary screening?A hereditary screening test checks if an individual has an inherited, genetic change in a gene with high cancer susceptibility from birth. Identifying the mutation that could cause cancer in the future is useful for people with cancer in their family history, and for people suspected of having a hereditary form of cancer. This knowledge can help with better medical planning and avoiding risk factors. HOW DOES CANCER DEVELOP? Cancer develops after certain genes that are responsible for keeping our body healthy undergo changes that cause them to become ‘faulty’. A cancer can be: SPORADIC: Mutations in the genes causing cancer accumulate over time due to risk factors like tobacco, viruses (such as HPV), and environmental factors. These mutations cannot be inherited. HEREDITARY: These mutations exist from birth. They run in families and can be passed down from parents to their children. What are germline mutations? Germline mutations are changes in the DNA that are inherited from parents to their children. These changes are present from birth in all the cells in the body. People with germline mutations in a cancer gene have a higher chance of developing cancer in their lifetime. If cancer develops due to a germline mutation, it is called hereditary cancer. What is a hereditary screening test? A hereditary screening test checks if an individual has an inherited gene mutation in a gene with high cancer susceptibility. f you or a family member were diagnosed with hereditary cancer, or a genetic change that is linked to cancer, there's a high chance other members of your family carry the genetic change as well. Each individual could be affected by cancer at different age, with wide range of severity, and by different cancer types. HEREDITARY CANCER PANEL • Includes 10,341 probes that target 113 genes related to cancer predisposition. • Hereditary Cancer Panel includes 125 SNPs. Of these, 48 are ID SNPs and 77 are used for polygenic risk scoring (PRS). • In combination with Illumina DNA Prep with Enrichment, Hereditary Cancer Panel enables genetic labs to prepare hybrid capture sequencing libraries in 6.5 hours with limited hands on time of ~2 hours. • Accommodates flexible workflows and is compatible with different sources of samples such as genomic DNA, saliva (Oragene tubes) or blood (Flex Lysis Reagent). SPECIFICATION WHO IS THIS TEST FOR? According to genetic testing guidelines* for cancer, people who might benefit from genetic testing are those that have: Family members with cancer in the same side of the family Multiple cancers in the same family member Family members with early cancer onset Family members with rare cancer types A family member that has been diagnosed with a genetic mutation that has cancer susceptibility Personal or family history of a hereditary cancer syndrome WHAT ARE ‘HEREDITARY CANCER SYNDROMES’? Hereditary cancer syndromes are also known as cancer predisposing syndromes, as patients with these syndromes have an elevated risk of developing specific cancers in the future. These conditions occur when genes with critical roles in keeping our body healthy are mutated, causing a variety of symptoms and potentially affecting the quality of life. They can be inherited from one generation to the other. Hereditary cancer syndromes characteristics • Multiple cancer types • Repeated cancers • Young age of cancer onset